1.3m switched to new ARV, but weight gain is a concern

1.3m switched to new ARV, but weight gain is a concern

Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.

Read More

Being young and living with HIV in the time of COVID-19

Being young and living with HIV in the time of COVID-19

Stigma and discrimination makes accessing healthcare services hard for many young people living with HIV. Has it become even harder during the COVID-19 pandemic? Nomfundo Xolo spoke to young people and activists in KwaZulu-Natal.

Read More

COVID-19: Lockdown, hunger and staying on HIV treatment in Hammonds Farm

COVID-19: Lockdown, hunger and staying on HIV treatment in Hammonds Farm

Concerns are mounting over people stopping or not starting tuberculosis and HIV treatment during South Africa’s COVID-19 lockdown. Nomfundo Xolo spoke to activists and people living with HIV and TB in Hammonds Farm in Verulam in KwaZulu-Natal about the challenges they face.

Read More

COVID-19: Pandemic puts pressure on medicine supply

COVID-19: Pandemic puts pressure on medicine supply

Reports of drug shortages and stock-outs across South Africa have the Department of Health in a race against the clock to ensure a supply of essential medicines. With manufacturing operations around the world still facing issues due to the COVID-19 pandemic, the country is battling to meet the demand for contraceptives, tuberculosis medicines and psychiatric medicines.

Read More

COVID-19: Is ‘normal’ healthcare being crowded out?

COVID-19: Is ‘normal’ healthcare being crowded out?

Many types of surgery are being delayed in South African hospitals. HIV and TB testing rates are down. Kathryn Cleary investigates the impact the COVID-19 pandemic is having on ‘normal’ healthcare in South Africa.

Read More

COVID-19: Regulation 11 should prevent promotion of quack treatments, but does it?

COVID-19: Regulation 11 should prevent promotion of quack treatments, but does it?

Tendai Mafuma describes what happened when SECTION27 tried to use new regulations to bring an end to the promotion of an unproven treatment for COVID-19 in South Africa and compares the current situation with the TAC’s successful court battle against Matthias Rath’s promotion of unproven AIDS treatments.

Read More

Special investigation: Claims of 90-90-90 success in KZN districts were premature

Special investigation: Claims of 90-90-90 success in KZN districts were premature

Last year KwaZulu-Natal celebrated three districts’ achievement of the UNAIDS 90-90-90 targets. But celebrations may have been premature, as new data shows that no district in KZN in fact met the targets. Spotlight visited one of the districts to investigate.

Read More